A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Viruses · 18.12.2024 · 16 (12) · 1936
DOI: 10.3390/v16121936 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Viruses, online erschienen am 18.12.2024. Verfasst von Polina Brangel und 55 weiteren Autor:innen. Beteiligte Einrichtung: World Health Organization, 1202 Geneva, Switzerland. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Laboratories, Antibodies, Viral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, FIC NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment of SARS-CoV-2 antigenicity. In this study, with the contribution of 15 independent laboratories across all WHO regions, we carried out a controlled analysis of neutralisation assay platforms using the first WHO International Standard for antibodies to SARS-CoV-2 variants of concern (source: NIBSC). Live virus isolates (source: WHO BioHub or individual labs) or spike plasmids (individual labs) for pseudovirus production were used to perform neutralisation assays using the same serum panels. When comparing fold drops, excellent data consistency was observed across the labs using common reagents, including between pseudovirus and live virus neutralisation assays (RMSD of data from mean fold drop was 0.59). Utilising a Bayesian model, geometric mean titres and assay titre magnitudes (offsets) can describe the data efficiently. Titre magnitudes were seen to vary largely even for labs within the same assay group. We have observed that overall, live Microneutralisation assays tend to have the lowest titres, whereas Pseudovirus Neutralisation have the highest (with a mean difference of 3.2 log2 units between the two). These findings are relevant for laboratory networks, such as the WHO Coronavirus Laboratory Network (CoViNet), that seek to support a global surveillance system for evolution and antigenic characterisation of variants to support monitoring of population immunity and vaccine composition policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- World Health Organization, 1202 Geneva, Switzerland.
- Centre for Pathogen Evolution, University of Cambridge, Cambridge CB3 0FD, UK.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Institute of Virology, Charitéplatz 1, 10117 Berlin, Germany.
- German Centre for Infection Research (DZIF), Associated Partner Site Charité, Charitéplatz 1, 10117 Berlin, Germany.
- WHO BioHub Facility, Spiez Laboratory, 3700 Spiez, Switzerland.
- Medicines and Healthcare Products Regulatory Agency, London SW1W 9SZ, UK.
ORCID-Profile: Sina Tureli, Barbara Mühlemann, Nicole Liechti, Daniel Zysset, Olivier Engler, Giada Mattiuzzo, Annika Rössler, Janine Kimpel, Luis Fernando Lopez Tort, Francis Amirtharaj Selvaraj, Penny L Moore, Samuel M S Cheng, Victor M Corman, Khadija Khan, Volker Thiel, G Tuba Barut, Irene Owusu Donkor, James Odame Aboagye, Bart L Haagmans, Derek Smith, Lorenzo Subissi
Förderung
- World Health Organization
- FIC NIH HHS
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- South African Research Chairs Initiative of the Department of Science and Innovation and National Research Foundation of South Africa
- SA Medical Research Council Strategic Health and Innovation Partnerships (SHIP) program
- Theme-based Research Scheme of the Research Grants Council of HKSAR
- Swiss National Science Foundation
Zitieren
APA
Brangel, P., Tureli, S., Mühlemann, B., Liechti, N., Zysset, D., Engler, O., Hunger-Glaser, I., Ghiga, I., Mattiuzzo, G., Eckerle, I., Bekliz, M., Rössler, A., Schmitt, M. M., Knabl, L., Kimpel, J., Tort, L. F. L., de Araujo, M. F., de Oliveira, A. C. A., Caetano, B. C., …, & Subissi, L. (2024). A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories. Viruses, 16(12), 1936. https://doi.org/10.3390/v16121936
Vancouver
Brangel P, Tureli S, Mühlemann B, Liechti N, Zysset D, Engler O, et al. A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories. Viruses. 2024;16(12):1936. doi:10.3390/v16121936
BibTeX
@article{Brangel2024,
author = {Brangel, Polina and Tureli, Sina and Mühlemann, Barbara and Liechti, Nicole and Zysset, Daniel and Engler, Olivier and Hunger-Glaser, Isabel and Ghiga, Ioana and Mattiuzzo, Giada and Eckerle, Isabella and Bekliz, Meriem and Rössler, Annika and Schmitt, Melanie M and Knabl, Ludwig and Kimpel, Janine and Tort, Luis Fernando Lopez and de Araujo, Mia Ferreira and de Oliveira, Any Caroline Alves and Caetano, Braulia Costa and Siqueira, Marilda Mendonça and Budt, Matthias and Gensch, Jean-Marc and Wolff, Thorsten and Hassan, Tarteel and Selvaraj, Francis Amirtharaj and Hermanus, Tandile and Kgagudi, Prudence and Crowther, Carol and Richardson, Simone I and Bhiman, Jinal N and Moore, Penny L and Cheng, Samuel M S and Li, John K C and Poon, Leo L M and Peiris, Malik and Corman, Victor M and Drosten, Christian and Lai, Lilin and Hunsawong, Taweewun and Rungrojcharoenkit, Kamonthip and Lohachanakul, Jindarat and Sigal, Alex and Khan, Khadija and Thiel, Volker and Barut, G Tuba and Ebert, Nadine and Mykytyn, Anna Z and Owusu Donkor, Irene and Aboagye, James Odame and Nartey, Prince Adom and Van Kerkhove, Maria D and Cunningham, Jane and Haagmans, Bart L and Suthar, Mehul S and Smith, Derek and Subissi, Lorenzo},
title = {A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories},
journal = {Viruses},
year = {2024},
volume = {16},
number = {12},
pages = {1936},
doi = {10.3390/v16121936}
}
EUVIMED